Refine
Year of publication
- 2024 (48)
- 2023 (92)
- 2022 (136)
- 2021 (136)
- 2020 (169)
- 2019 (196)
- 2018 (169)
- 2017 (154)
- 2016 (157)
- 2015 (162)
- 2014 (160)
- 2013 (171)
- 2012 (162)
- 2011 (183)
- 2010 (181)
- 2009 (179)
- 2008 (150)
- 2007 (137)
- 2006 (129)
- 2005 (122)
- 2004 (150)
- 2003 (95)
- 2002 (123)
- 2001 (103)
- 2000 (102)
- 1999 (109)
- 1998 (98)
- 1997 (96)
- 1996 (81)
- 1995 (78)
- 1994 (87)
- 1993 (59)
- 1992 (54)
- 1991 (29)
- 1990 (39)
- 1989 (44)
- 1988 (56)
- 1987 (32)
- 1986 (19)
- 1985 (33)
- 1984 (22)
- 1983 (20)
- 1982 (29)
- 1981 (20)
- 1980 (36)
- 1979 (24)
- 1978 (34)
- 1977 (14)
- 1976 (13)
- 1975 (12)
- 1974 (3)
- 1973 (2)
- 1972 (2)
- 1971 (1)
- 1968 (1)
Institute
- Fachbereich Medizintechnik und Technomathematik (1571)
- Fachbereich Elektrotechnik und Informationstechnik (712)
- IfB - Institut für Bioengineering (566)
- Fachbereich Energietechnik (562)
- Fachbereich Chemie und Biotechnologie (539)
- INB - Institut für Nano- und Biotechnologien (533)
- Fachbereich Luft- und Raumfahrttechnik (481)
- Fachbereich Maschinenbau und Mechatronik (267)
- Fachbereich Wirtschaftswissenschaften (207)
- Solar-Institut Jülich (161)
Has Fulltext
- no (4713) (remove)
Language
- English (4713) (remove)
Document Type
- Article (3205)
- Conference Proceeding (1039)
- Part of a Book (195)
- Book (146)
- Doctoral Thesis (32)
- Conference: Meeting Abstract (29)
- Patent (25)
- Other (10)
- Report (10)
- Conference Poster (5)
Keywords
- Gamification (6)
- avalanche (6)
- Earthquake (5)
- Enterprise Architecture (5)
- MINLP (5)
- solar sail (5)
- Additive manufacturing (4)
- Diversity Management (4)
- Energy storage (4)
- Engineering optimization (4)
In humans, 75% of all drugs are metabolized by the cytochrome P450-dependent monooxygenase system. Enzymes encoded by the CYP2C, CYP2D, and CYP3A gene clusters account for ∼80% of this activity. There are profound species differences in the multiplicity of cytochrome P450 enzymes, and the use of mouse models to predict pathways of drug metabolism is further complicated by overlapping substrate specificity between enzymes from different gene families. To establish the role of the hepatic and extrahepatic P450 system in drug and foreign chemical disposition, drug efficacy, and toxicity, we created a unique mouse model in which 30 cytochrome P450 genes from the Cyp2c, Cyp2d, and Cyp3a gene clusters have been deleted. Remarkably, despite a wide range of putative important endogenous functions, Cyp2c/2d/3a KO mice were viable and fertile, demonstrating that these genes have evolved primarily as detoxification enzymes. Although there was no overt phenotype, detailed examination showed Cyp2c/2d/3a KO mice had a smaller body size (15%) and larger livers (20%). Changes in hepatic morphology and a decreased blood glucose (30%) were also noted. A five-drug cocktail of cytochrome P450 isozyme probe substrates were used to evaluate changes in drug pharmacokinetics; marked changes were observed in either the pharmacokinetics or metabolites formed from Cyp2c, Cyp2d, and Cyp3a substrates, whereas the metabolism of the Cyp1a substrate caffeine was unchanged. Thus, Cyp2c/2d/3a KO mice provide a powerful model to study the in vivo role of the P450 system in drug metabolism and efficacy, as well as in chemical toxicity.
An array of electrically isolated nanoplate field-effect silicon-on-insulator (SOI) capacitors as a new transducer structure for multiparameter (bio-)chemical sensing is presented. The proposed approach allows addressable biasing and electrical readout of multiple nanoplate field-effect capacitive (bio-)chemical sensors on the same SOI chip, as well as differential-mode measurements. The realized sensor chip has been applied for pH and penicillin concentration measurements, electrical monitoring of polyelectrolyte multilayer formation, and the label-free electrical detection of consecutive deoxyribonucleic acid (DNA) hybridization and denaturation events.